buprenorphine and naloxone
buprenorphine and naloxone is listed in the FDA National Drug Code directory with 13 NDC codes, marketed under brand name including Buprenorphine and Naloxone. Available dosage forms: film, film, soluble.
Drug Details
- Generic Name
- buprenorphine and naloxone
- Brand Names
- Buprenorphine and Naloxone
- Application Number
- ANDA212756
- Sponsor
- Redpharm Drug
- NDC Codes
- 13
- Dosage Forms
- FILM, FILM, SOLUBLE
- Routes
- BUCCAL, SUBLINGUAL
- Active Ingredients
- BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablets contain buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )